CXCR4 chemokine antagonist scores a first FDA approval for WHIM syndrome.
Nat Rev Drug Discov
; 23(6): 411, 2024 06.
Article
in En
| MEDLINE
| ID: mdl-38740965
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
United States Food and Drug Administration
/
Drug Approval
/
Receptors, CXCR4
/
Primary Immunodeficiency Diseases
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Nat Rev Drug Discov
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2024
Document type:
Article
Country of publication:
United kingdom